Infectious vulvovaginitis: Current trends and management

Journal of Pharmacy Technology

Volumn 16, Issue 3, 2000, Pages 92-97

  Ponte, Charles D ^a  

^a WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN; HYDROGEN PEROXIDE; METRONIDAZOLE;

ARTICLE; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDIASIS; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; DYSPAREUNIA; DYSURIA; ECOSYSTEM; HUMAN; OPPORTUNISTIC INFECTION; PH; PREGNANCY COMPLICATION; PREVALENCE; PUBLICATION; TREATMENT PLANNING; TRICHOMONAS VAGINALIS; TRICHOMONIASIS; VAGINITIS; VULVOVAGINITIS;

EID: 0034083176     PISSN: 87551225     EISSN: None     Source Type: Journal    
DOI: 10.1177/875512250001600305     Document Type: Article

References (32)

1. Haefner HK. Current evaluation and management of vulvovaginitis. Clin Obstet Gynecol 1999;42:184-95.
2. Kent HL. Epidemiology of vaginitis. Am J Obstet Gynecol 1991;165: 1168-76.
3. Mardh P-A. The vaginal eosystem. Am J Obstet Gynecol 1991;165 (suppl pt. 2):1163-8.
4. Spinillo A, Capuzzo E, Gulminetti R, Marone P, Colonna L, Piazza G. Prevalence of and risk factors for fungal vaginitis caused by non-albicans species. Am J Obstet Gynecol 1997;176:138-41.
5. Carcio HA, Secor RMC. Vulvovaginal candidiasis: a current up-date. Nurse Pract Forum 1992;3:135-44.
6. Rodriques AG, Mardh P-A, Pina-Vaz C, Martinez-de-Oliveira J, daFonseca AF. Is the lack of concurrence of bacterial vaginosis and vaginal candidosis explained by the presence of bacterial amines? Am J Obstet Gynecol 1999;181:367-70.
7. Horowitz BJ, Edelstein SW, Lippman L. Sexual transmission of candida. Obstet Gynecol 1987;69:883-6.
8. Nyirjesy P. Vaginitis in the adolescent patient. Pediatr Clin North Am 1999;46:733-45.
9. Bossche HV, Marichal P. Mode of action of anti-Candida drugs: focus on terconazole and other ergosterol biosynthesis inhibitors. Am J Obstet Gynecol 1991;165(suppl pt. 2):1193-9.
10. Sobel JD, Chaim W. Treatment of Torulopsis glabrata vaginitis: retrospective review of boric acid therapy Clin Infect Dis 1997;24:649-52.
11. Vazquez JA, Sobel JD, Peng G, Steele-Moore L, Schuman P, Holloway W, et al. Evolution of vaginal Candida species recovered from human immunodeficiency virus-infected women receiving fluconazole prophylaxis: the emergence of Candida glabrata? Clin Infect Dis 1999;28:1025-31.
12. Cates W. Estimates of the incidence and prevalence of sexually transmitted diseases in the United States Sex Transm Dis 1999;26 (suppl 4):S2-7.
13. Spence MR, Harwell TS, Davies MC, Smith JL. The minimum single oral metronidazole dose for treating trichomoniasis: a randomized, blinded study. Obstet Gynecol 1997;89:699-703.
14. Sobel JD, Nagappan V, Nyirjesy P. Metronidazole-resistant vaginal trichomoniasis - an emerging problem. N Engl J Med 1999; 341:292-3.
15. Burtin P, Taddio A, Ariburnu O, Einarson R, Koren G. Safety of metronidazole in pregnancy: a meta-analysis. Am J Obstet Gynecol 1995;172:525-9.
16. Spiegel CA. Bacterial vaginosis. Clin Microbiol Rev 1991;4:485-502.
17. Rajamanoharan S, Low N, Jones SB, Pozniak AL. Bacterial vaginosis, ethnicity, and the use of genital cleaning agents: a case control study. Sex Transm Dis 1999;26:404-9.
18. Merchant JS, Oh MK, Klerman V. Douching - a problem for adolescent girls and young women. Arch Pediatr Adolesc Med 1999; 153:834-7.
19. Roy S. Nonbarrier contraceptives and vaginitis and vaginosis. Am J Obstet Gynecol 1991;165:1240-4.
20. Addison LA. The role of the office laboratory in the diagnosis of vaginitis. Prim Care 1986;13:633-46.
21. Eschenbach DA, Hillier S, Critchlow C, Stevens C, DeRousen T, Holmes KK. Diagnosis and clinical manifestations of bacterial vaginosis. Am J Obstet Gynecol 1988;158:819-28.
22. Amsel R, Totten PA, Spiegel CA, Chen KCS, Eschenbach D, Holmes KK. Nonspecific vaginitis: diagnostic criteria and microbial and epidemiologic associations. Am J Med 1983;74:14-22.
23. Wilson JD, Ralph SG, Jackson F, Rutherford AJ. Infertility, preterm birth, and bacterial vaginosis (letter). Lancet 1999;354:511.
24. Centers for Disease Control and Prevention: 1998 Guidelines for treatment of sexually transmitted diseases. MMWR Morb Mortal Wkly Rep 1998;47(No. RR-1):72.
25. Lugo-Miro VI, Green M, Mazur L. Comparison of different metronidazole therapeutic regimens for bacterial vaginosis: a meta-analysis. JAMA 1992;268:92-5.
26. The pink sheet. Searle Flagyl ER once daily for bacterial vaginosis to be launched 1Q 1998. F-D-C Rep 1997:1-2.
27. Greaves WI, Chungafung J, Morris B, Haile A, Townsend JL. Clindamycin versus metronidazole in the treatment of bacterial vaginosis. Obstet Gynecol 1990;72:799-802.
28. Schmitt C, Sobel JD, Meriwether C. Bacterial vaginosis: treatment with clindamycin cream versus oral metronidazole. Obstet Gynecol 1992;79:1020-3.
29. Clinical monograph. MetroGel-Vaginal. Elk Grove Village, IL: Curatek Pharmaceuticals, September 1992.
30. Livengood CH, Soper DE, Sheehan K, Fenner DE, Martens MG, Nelson AL, et al. Comparison of once-daily and twice-daily dosing of 0.75% metronidazole gel in the treatment of bacterial vaginosis. Sex Transm Dis 1999;26:137-42.
31. ACNM Clinical Bulletins. American College of Nurse-Midwives. Clinical Bulletin No. 4, December 1998. Bacterial vaginosis in pregnancy. J Nurse Midwifery 1999;44:129-34.
32. Morales WJ, Schoor S, Albritton J. Effect of metronidazole in patients with preterm birth in a preceding pregnancy and bacterial vaginosis: a placebo-controlled, double blind study. Am J Obstet Gynecol 1994;171:345-9.